Effect of Unique Retinal Environment on Catalytic Properties of Cholesterol-Metabolizing P450s

被引：0
|
作者：
Heo, G. [1 ]
Mast, N. [1 ]
Pikuleva, I. A. [1 ]
Liao, W. -L. [2 ]
Turko, I. V. [2 ]
机构：
[1] Case Western Reserve Univ, Ophthalmol &Visual Sci, Cleveland, OH 44106 USA
[2] NIST, Ctr Adv Res Biotechnol, UMBI, Rockville, MD 20850 USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2010年 / 51卷 / 13期
关键词：
retina; retinal pigment epithelium;
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
5951
引用
收藏
页数：2
相关论文
共 50 条
  • [41] A novel cytochrome P450 mono-oxygenase from Streptomyces platensis resembles activities of human drug metabolizing P450s
    Worsch, Anne
    Eggimann, Fabian Kurt
    Girhard, Marco
    von Buehler, Clemens J.
    Tieves, Florian
    Czaja, Rico
    Vogel, Andreas
    Grumaz, Christian
    Sohn, Kai
    Luetz, Stephan
    Kittelmann, Matthias
    Urlacher, Vlada B.
    BIOTECHNOLOGY AND BIOENGINEERING, 2018, 115 (09) : 2156 - 2166
  • [42] Effects of Vernonia cinerea Compounds on Drug-metabolizing Cytochrome P450s in Human Liver Microsomes
    Pouyfung, Phisit
    Sarapusit, Songklod
    Rongnoparut, Pornpimol
    PHYTOTHERAPY RESEARCH, 2017, 31 (12) : 1916 - 1925
  • [43] Monocrotophos Induced Apoptosis in PC12 Cells: Role of Xenobiotic Metabolizing Cytochrome P450s
    Kashyap, Mahendra Pratap
    Singh, Abhishek Kumar
    Kumar, Vivek
    Tripathi, Vinay Kumar
    Srivastava, Ritesh Kumar
    Agrawal, Megha
    Khanna, Vinay Kumar
    Yadav, Sanjay
    Jain, Swatantra Kumar
    Pant, Aditya Bhushan
    PLOS ONE, 2011, 6 (03):
  • [44] End-stage renal disease reduces the expression of drug-metabolizing cytochrome P450s
    Deri, Mate Tamas
    Kiss, Adam Ferenc
    Toth, Katalin
    Paulik, Jozsef
    Sarvary, Eniko
    Kobori, Laszlo
    Monostory, Katalin
    PHARMACOLOGICAL REPORTS, 2020, 72 (06) : 1695 - 1705
  • [45] Microsomal cytochrome P4502C5: comparison to microbial P450s and unique features
    Williams, PA
    Cosme, J
    Sridhar, V
    Johnson, EF
    McRee, DE
    JOURNAL OF INORGANIC BIOCHEMISTRY, 2000, 81 (03) : 183 - 190
  • [46] End-stage renal disease reduces the expression of drug-metabolizing cytochrome P450s
    Máté Tamás Déri
    Ádám Ferenc Kiss
    Katalin Tóth
    József Paulik
    Enikő Sárváry
    László Kóbori
    Katalin Monostory
    Pharmacological Reports, 2020, 72 : 1695 - 1705
  • [47] Inhibition of drug metabolizing cytochrome P450s (CYPs) by the aromatase inhibitor drug letrozole in vitro.
    Jeong, S.
    Ward, B. A.
    Flockhart, D. A.
    Desta, Z.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 : S74 - S74
  • [48] Polycyclic aromatic hydrocarbon metabolizing cytochrome P450s in freshly prepared uncultured rat blood lymphocytes
    Saurabh, Kumar
    Sharma, Amit
    Yadav, Sanjay
    Parmar, Devendra
    BIOCHEMICAL PHARMACOLOGY, 2010, 79 (08) : 1182 - 1188
  • [49] Extending the capabilities of nature's most versatile catalysts: Directed evolution of mammalian xenobiotic-metabolizing P450s
    Gillam, Elizabeth M. J.
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2007, 464 (02) : 176 - 186
  • [50] Regulation of cytochrome P450S catalytic activities by means of physico-chemical methods
    Shumyantseva, VV
    Bulko, TV
    Archakov, AI
    USPEKHI KHIMII, 1999, 68 (10) : 967 - 975
12345